# EPIC-17-IMP-08 — Final Conformance & Closure Gate

**Status:** `COMPLETE / CTO ACCEPTED / CLOSED`
**Type:** conformance and documentation only
**Closure baseline:** `42ba13ee86901637507008ac2ef260985e5c0801` (`origin/dev`)
**Date:** September 15, 2026
**Schema:** `12 / CANONICAL / UNCHANGED`
**Schema 13:** `NOT REQUIRED / NOT AUTHORIZED`
**Functional implementation during closure:** none

## Final determination

```text
IMP-08 FINAL CONFORMANCE: PASS
Remaining required implementation: NONE
Recommendation: READY TO RELEASE THE IMP-09 EVALUATION DEPENDENCY GATE
```

S5 reconciles the accepted freeze with the published S1, S2 and S4 evidence.
It introduces neither a Genome owner nor a further functional slice.

## Published inventory

| Slice | Published SHA | Accepted result | Conformance basis |
| --- | --- | --- | --- |
| Freeze | `c31d58a5e707651d7702b427f629c0a3cc770a82` | bounded descriptive semantics | Genome is not Agent identity, AgentRevision, authority or execution configuration. |
| S1 | `425485ce2b09777a5af997a18726554acbf9236c` | Genome/Trait contracts | current/exact subject addressing, exact historical gaps, typed trait assertions, provenance and verification references. |
| S2 | `fd03ee04e0acf32af927864d5c2955cca0cc7ccb` | presentation/verification associations | immutable artifact references, explicit presentation availability gaps and descriptive verification status. |
| S3 | n/a | `SKIPPED / NOT REQUIRED` | Persistence impact A remained uncontradicted. |
| S4 | `42ba13ee86901637507008ac2ef260985e5c0801` | safe administrative projection | existing administrative query seam and Product API GET route, Tenant enforcement and allowlisted disclosure. |

## Cross-domain conformance

| Required property | Result | Evidence |
| --- | --- | --- |
| Genome remains descriptive-only | PASS | S1 contract exclusions; S4 read source port receives canonical source contracts and has no mutation method. |
| Canonical Agent ownership remains external | PASS | S1 `GenomeSubjectV1` references current Agent or exact AgentRevision only; S4 resolves subject identity through canonical Agent lineage. |
| Exact history has no current/latest fallback | PASS | S1 returns `GENOME_EXACT_SUBJECT_UNAVAILABLE`; S4 returns the same explicit historical gap projection for an unavailable revision. |
| Revision and fingerprint are enforced | PASS | S4 exact Product API query requires both fields and rejects mismatched fingerprints. |
| Tenant isolation and non-disclosure | PASS | Existing HTTP authentication/membership boundary precedes `AdministrativeQueryService`; foreign subject lookup is non-disclosing. |
| Trait, provenance, Evidence and verification remain separate | PASS | Trait assertions retain `SourceReferenceV2`, Evidence `EntityRef` values and descriptive verification references; S4 exposes references/status only. |
| Presentation availability is descriptive | PASS | S2 association preserves immutable artifact identity and explicit availability/gap state; S4 exposes unavailable state without invalidating the assertion. |
| Safe Product API boundary | PASS | One existing Product API route family, `GET /api/v1/genomes/agents/:agentId`; no direct repository mutation, parallel service or Genome write route. |
| Authority, Runtime and economics remain absent | PASS | No capability/permission/delegation derivation, verification authority, admission/runtime behavior, economic/NFT semantics or write surface exists in the accepted slices. |
| Persistence impact A remains valid | PASS | No Genome table, repository, migration or Schema 12 change. Schema 13 was not introduced. |

## Disclosure and ownership result

The administrative representation is an allowlist. It exposes scalar trait
metadata, reference counts, verification status and presentation availability.
It redacts JSON trait payloads and does not disclose raw Evidence, provenance
payloads, artifact storage/content, provider payloads, credentials or Runtime
state. A Genome identifier remains a reference; it does not authorize reading
the referenced object.

Verification visibility is descriptive only. The S4 route cannot issue,
promote, revoke or interpret verification as authority. Presentation
unavailability is also descriptive and never changes Trait assertion state.

## Validation and regression causality

| Check | Result |
| --- | --- |
| Build | PASS — `npm run build` |
| Focused IMP-08 S1/S2/S4 | PASS — 3 files / 0 failures |
| S4 Product/API, exact history, gap, disclosure and Tenant tests | PASS — `tests/epic-17-imp-08-s4-genome-administration.test.mjs` |
| PostgreSQL acceptance | PASS — Schema 12, 28 pass / 0 fail / 0 skip |
| `git diff --check` | PASS |
| Full parallel regression | CLASSIFIED — 814 pass / 29 skipped / 2 failed |
| Collision reruns | PASS — `s32-operational-reliability` and `s44-epic-15-tenant-administration-product-api` passed individually |

The two parallel failures were `RuntimePersistenceError` while opening local
SQLite runtime state in `s32` and `s44`. They did not execute the Genome source
port, projection, route or contracts; both passed on immediate isolated rerun.
S5 classifies them as test-harness concurrency/environmental collisions, not
S4 functional regressions. The original parallel result is retained above and
is not rewritten as `0 fail`.

## Scope and stop-condition review

```text
Genome persistence: NONE
Migration: NONE
Schema 12: UNCHANGED
Schema 13: NOT INTRODUCED
Runtime / Admission: NONE
Verification authority: NONE
Genome writes: NONE
Parallel Product API: NONE
Economic / NFT semantics: NONE
Architecture contradiction: NONE
CEO decision: NONE
```

No S4 or S5 finding requires a physical-design review. S3 remains correctly
recorded as `SKIPPED / NOT REQUIRED` rather than implemented merely to complete
the slice sequence.

## CTO closure disposition

```text
EPIC-17-IMP-08
Genome Traits, Assets & Verification

FINAL CONFORMANCE: PASS
Status: COMPLETE / CTO ACCEPTED / CLOSED
IMP-09 dependency gate: RELEASED FOR EVALUATION ONLY
Implementation authorization for IMP-09: SEPARATE / REQUIRED
```
